New treatments for NASH- BAR502 a novel FXR/TGR5 ligand protects against liver steatohepatitis
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis
Carino A. et al. Scientific Reports 7, Article number: 42801 (2017)- doi:10.1038/srep42801
Leave a reply →
Post più commentati